Luyan Pharma Co.,Ltd. (002788.SZ)
- Previous Close
8.07 - Open
8.08 - Bid 8.02 x --
- Ask 8.03 x --
- Day's Range
8.01 - 8.13 - 52 Week Range
6.88 - 9.56 - Volume
3,750,150 - Avg. Volume
4,703,826 - Market Cap (intraday)
3.12B - Beta (5Y Monthly) --
- PE Ratio (TTM)
9.45 - EPS (TTM)
0.85 - Earnings Date --
- Forward Dividend & Yield 0.30 (3.74%)
- Ex-Dividend Date Jul 4, 2024
- 1y Target Est
--
Luyan Pharma Co.,Ltd. distributes and sells medicines, Chinese herbal medicines, medical devices, and vaccines in China. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 2008 and is headquartered in Xiamen, China.
www.luyan.com.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 002788.SZ
View MorePerformance Overview: 002788.SZ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002788.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002788.SZ
View MoreValuation Measures
Market Cap
3.12B
Enterprise Value
7.79B
Trailing P/E
9.45
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
0.96
Enterprise Value/Revenue
0.38
Enterprise Value/EBITDA
12.10
Financial Highlights
Profitability and Income Statement
Profit Margin
1.62%
Return on Assets (ttm)
3.41%
Return on Equity (ttm)
10.59%
Revenue (ttm)
20.51B
Net Income Avi to Common (ttm)
333.19M
Diluted EPS (ttm)
0.85
Balance Sheet and Cash Flow
Total Cash (mrq)
457.88M
Total Debt/Equity (mrq)
157.33%
Levered Free Cash Flow (ttm)
246M